Evolving landscape of PARP inhibitors in mCRPC: combination with anti-androgens
Module 2 of 2
EACCME®
2 modules required for CME credit
Genitourinary Oncology60 min
Incorporating PARP inhibitors into prostate cancer clinical practice
EACCME®
Genitourinary Oncology60 min
Targeting advanced prostate cancer with PARP inhibitors: Who, When and How?
EACCME®
Genitourinary Oncology60 min
PARP inhibitors in Prostate Cancer
EACCME®
Genitourinary Oncology30 min
Radiopharmaceuticals in prostate cancer
Episode 1: radium-223
EACCME®
Genitourinary Oncology30 min
Radiopharmaceuticals in prostate cancer
Episode 2: PSMA Theranostics
EACCME®
Genitourinary Oncology60 min
Current opinions on managing nmCRPC and the implications of new imaging modalities
EACCME®
Genitourinary Oncology60 min
The SHARE Communication Framework Supporting Physicians In Shared Decision-Making With Patients Treated For Metastatic Castration Resistant Prostate Cancer (mCRPC)
EACCME® ACCME ABIM
Genitourinary Oncology60 min
Treatment sequencing for mCRPC patients within the changing landscape of mHSPC
All courses
EACCME®
ACCME
ABIM
